Annapolis News Updates

Biopharmaceutical Third Party Logistics (3PL) Market Size Is Expected To Reach USD 120.64 Billion By 2025 | Radiant Insights, Inc.

 Breaking News
  • No posts were found

Biopharmaceutical Third Party Logistics (3PL) Market Size Is Expected To Reach USD 120.64 Billion By 2025 | Radiant Insights, Inc.

April 10
12:14 2019
Biopharmaceutical Third Party Logistics (3PL) Market Size Is Expected To Reach USD 120.64 Billion By 2025 | Radiant Insights, Inc.

” Radiant Insights, Inc” 
The report covers the present scenario and the growth prospects of the biopharmaceutical third party logistics (3PL) market 2019-2025.

The global biopharmaceutical third party logistics (3PL) market size is expected to reach USD 120.64 billion by 2025, at a CAGR 4.9% over the forecast period, according to a new report by Radiant Insights. The market for biopharmaceutical third party logistics (3PL) is majorly driven by rising demand for temperature controlled logistic services to transport biologics in various regions and growing distribution networks of biopharmaceutical companies to improve their sales. Rising adoption of automated storage and retrieval systems in the emerging countries is an ongoing trend in the pharmaceutical logistics companies that has gained a significant traction.

Furthermore, the trend of shifting from small molecule drugs to biopharmaceuticals, mainly vaccines and biologics, is projected to drive the market. Since, these small molecule drugs are temperature sensitive products, demand for temperature controlled transportation and storage increases and thus is responsible for the market growth. As of now, the pharmaceutical sales through distributors have grown from USD 304.6 billion in 2013 to USD 440.2 billion in 2016. However, the average number of manufacturers per distributor had declined from 1,474 in 2014 to 1,211 in 2016. This data depicts that there is an increase in quantity of pharmaceutical products being distributed, and thus, is expected to surge the demand for 3PL services.

Request a Free Sample Copy of this Report @ https://www.radiantinsights.com/research/biopharmaceutical-third-party-logistics-3pl-market/request-sample

Additionally, environmental concerns and cost have caused a slight shift in the means of transport used for commercial product, moving from airway to seaway shipping and in roadways from truck to intermodal (both rail and truck). The intermodal transport is majorly used by these pharmaceutical companies to reduce the carbon footprint. The ongoing trend shows that the pharmaceutical manufacturers have shifted towards sea freight to reduce the cost and risk factor. Although for cold chain products, the companies still prefer air freight. However, some of the large pharmaceutical companies are planning to transport 70% of their products via ocean freight including cold chain products.

Further key findings from the report suggest:

• In 2018, non-cold chain logistics held the largest market share in terms of revenue owing to the sales of a large number of drugs that do not require any temperature control

• Cold chain logistics segment is expected to register the faster CAGR over the forecast period owing to the demand for biologics, such as cellular therapies, vaccines, and test kits

• Warehousing and storage held the largest market share among the types of services in 2018

• Asia pacific expected to emerge with the fastest CAGR over the forecast period owing to adoption of medicines from aging population and shift of drug sales from brand manufacturers to generic

• Key players operating in the biopharmaceutical third party logistics market include DHL International GmbH., SF Express, United Parcel Service of America, Inc, AmerisourceBergen Corporation, DB Schenker, Kuehne and Nagel, Kerry logistics network limited and Agility

Download Full Research Report of Biopharmaceutical Third Party Logistics (3PL) Market @ https://www.radiantinsights.com/research/biopharmaceutical-third-party-logistics-3pl-market

Table of Contents

Chapter 1 Research Methodology
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.2 Primary Research:
1.2.1 List of primary sources include

Chapter 2 Executive Summary
2.1 Market Snapshot, 2018 (USD Million)

Chapter 3 Biopharmaceutical Third Party Logistics Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.3 Market Restraint Analysis
3.4 Penetration & Growth Prospect Mapping
3.5 Biopharmaceutical Third Party Logistics Market – SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis – Porter’s

Chapter 4 Biopharmaceutical Third Party Logistics Market: Supply Chain Estimates & Trend Analysis
4.1 Biopharmaceutical Third Party Logistics Market: Supply Chain Movement Analysis (USD Million), 2018 & 2025
4.2 Cold Chain Logistics
4.2.1 Cold chain logistics market revenue estimates and forecasts, 2014 – 2025 (USD Million)
4.3 Non-cold Chain Logistics
4.3.1 Non-cold chain logistics market revenue estimates and forecasts, 2014 – 2025 (USD Million)

Read more related reports by Radiant Insights:

• Healthcare 3D Printing Market – https://www.radiantinsights.com/research/global-healthcare-3d-printing-market-research-report-2019

Healthcare 3D Printing Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and in-depth research report on the world’s major regional market conditions, focusing on the main regions and the main countries.

• Diabetes Disposable Insulin Pen Market – https://www.radiantinsights.com/research/global-diabetes-disposable-insulin-pen-market-research-report-2019

Diabetes Disposable Insulin Pen Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and in-depth research report on the world’s major regional market conditions, focusing on the main regions and the main countries.

 

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: Send Email
Phone: (415) 349-0054, Toll Free: 1-888-928-9744
Address:201 Spear Street 1100, Suite 3036
City: San Francisco
State: CA
Country: United States
Website: www.radiantinsights.com/research/biopharmaceutical-third-party-logistics-3pl-market

Categories